# CSRP2

## Overview
The CSRP2 gene encodes the cysteine and glycine-rich protein 2 (CRP2), a member of the LIM domain protein family, which is characterized by its involvement in protein-protein interactions through its zinc finger motifs. CRP2 plays a crucial role in various cellular processes, including cytoskeletal organization, cell differentiation, and transcriptional regulation. It is predominantly expressed in vascular smooth muscle cells, where it contributes to maintaining their differentiated and contractile state, essential for vascular function (Wu2014Divergent; Lin2008Transforming). The protein's ability to localize to both the cytosol and nucleus allows it to participate in cytoskeletal stabilization and transcriptional regulation, respectively. CRP2's interactions with other proteins, such as zyxin and α-actinin, underscore its role in cytoskeletal dynamics, while its involvement with transcription factors like serum response factor (SRF) highlights its regulatory functions in gene expression (Sagave2008Targeted). Additionally, CRP2 has been implicated in pathological conditions, including cancer and cardiovascular diseases, where its expression levels and interactions influence disease progression and prognosis (Chen2020CSRP2; Wang2020&lt).

## Structure
The CSRP2 gene encodes the cysteine and glycine-rich protein 2 (CRP2), which is characterized by the presence of two LIM domains. These domains are zinc finger motifs that facilitate protein-protein interactions and are structurally independent, connected by a flexible linker region (Kloiber1999Mutational; Weiskirchen2003The). The LIM domains in CRP2 are composed of zinc-binding motifs, with the LIM1 domain containing CCHC and CCCC fingers, each comprising two orthogonally arranged antiparallel beta-sheets packed by a hydrophobic core (Weiskirchen2003The). The LIM2 domain also features antiparallel beta-sheets and is linked by intermodular hydrogen bonds or salt bridges (Weiskirchen2003The).

CRP2 shares structural similarities with the DNA-binding domain of the GATA-1 transcription factor, suggesting potential DNA-binding capabilities, although direct DNA affinity has not been experimentally confirmed (Weiskirchen2003The). The protein exhibits a bimodal subcellular distribution, localizing to both the cytosol and nucleus, facilitated by a nuclear targeting signal (Weiskirchen2003The). The LIM domains' intrinsic segmental flexibility is crucial for their function in forming macromolecular complexes, either in nuclear transcription complexes or cytoskeletal complexes (Kloiber1999Mutational). The protein's structure is stabilized by zinc ions, which are coordinated by cysteine and histidine residues (Weiskirchen1995The).

## Function
The CSRP2 gene encodes the cysteine and glycine-rich protein 2 (CRP2), a LIM domain protein that plays a significant role in cellular processes such as cytoskeletal organization, cell differentiation, and transcriptional regulation. CRP2 is primarily expressed in vascular smooth muscle cells (VSMCs) and is involved in maintaining the quiescent, differentiated, and contractile state of these cells, which is crucial for regulating vascular tone and blood pressure (Wu2014Divergent; Lin2008Transforming). 

CRP2 has a bimodal subcellular distribution, accumulating at actin-based filaments in the cytosol and in the nucleus. It interacts with proteins like zyxin, α-actinin, and α-actin, suggesting a role in organizing or stabilizing cytoskeletal structures (Sagave2008Targeted). In the nucleus, CRP2 acts as a cofactor for transcription factors such as serum response factor (SRF) and GATA proteins, facilitating the expression of smooth muscle marker genes (Sagave2008Targeted). 

CRP2 is also involved in the response to vascular injury, where its expression is modulated by transforming growth factor β (TGFβ), which upregulates CRP2 via activating transcription factor 2 (ATF2) (Lin2008Transforming). This regulation is important for inhibiting VSMC migration and neointima formation, thus playing a protective role against pathological vascular remodeling (Wu2014Divergent).

## Clinical Significance
Alterations in the expression of the CSRP2 gene have been linked to various diseases, particularly in the context of cancer. In acute myeloid leukemia (AML), low expression levels of CSRP2 are associated with a higher cumulative incidence of relapse and worse relapse-free survival, especially in patients treated with chemotherapy alone. Knockdown of CSRP2 in AML cell lines promotes cell proliferation and cell cycle progression, potentially through the AKT and CREB signaling pathways, suggesting that CSRP2 could serve as a prognostic biomarker and therapeutic target in AML management (Wang2020&lt; p&gt; Inhibition).

In other cancers, high expression of CSRP2 is linked to increased metastasis risk in breast cancer and poor prognosis in adult B-ALL patients with a normal karyotype. Conversely, downregulation of CSRP2 enhances proliferation and motility in gastric cancer cells (Wang2020&lt; p&gt; Inhibition). The expression of CSRP2 may be influenced by genetic mutations, such as KMT2A rearrangement in BCP ALL and FLT3-ITD mutations in AML, which correlate with adverse outcomes (Wang2020&lt; p&gt; Inhibition).

In the cardiovascular system, CRP2, the protein encoded by CSRP2, is involved in the organization of the cytoskeleton in cardiac muscle cells. Disruption of the Csrp2 gene in mice results in subtle cardiac ultrastructural changes, such as increased cardiomyocyte thickness, indicating moderate hypertrophy (Sagave2008Targeted).

## Interactions
CSRP2, a LIM domain protein, is involved in various protein interactions that contribute to its role in cellular processes. It interacts with the protein inhibitor of activated STAT1 (PIAS1), a relationship confirmed through co-localization and co-immunoprecipitation assays. This interaction occurs in both the cytoskeleton and the nucleus, suggesting a role in cellular signaling pathways, particularly the JAK/STAT pathway (WEISKIRCHEN2001LIMdomain).

CSRP2 also binds directly to F-actin, independent of other proteins like K-actinin and zyxin, indicating its autonomous actin-binding capability. This interaction is crucial for its role in stabilizing actin filaments and organizing the cytoskeleton (Grubinger2003CRP2).

In the context of colorectal cancer, CSRP2 interacts with p130Cas, inhibiting its phosphorylation and subsequently suppressing Rac1 activation. This interaction affects several signaling pathways, including the ERK, PAK/LIMK/cortactin, and Hippo pathways, thereby inhibiting epithelial-mesenchymal transition and metastasis (Chen2020CSRP2).

These interactions highlight CSRP2's multifaceted role in cellular dynamics and its potential as a therapeutic target in diseases like cancer.


## References


[1. (Weiskirchen1995The) Ralf Weiskirchen, Josephine D. Pino, Teresita Macalma, Klaus Bister, and Mary C. Beckerle. The cysteine-rich protein family of highly related lim domain proteins. Journal of Biological Chemistry, 270(48):28946–28954, December 1995. URL: http://dx.doi.org/10.1074/jbc.270.48.28946, doi:10.1074/jbc.270.48.28946. This article has 99 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.270.48.28946)

[2. (Chen2020CSRP2) Lixia Chen, Xiaoli Long, Shiyu Duan, Xunhua Liu, Jianxiong Chen, Jiawen Lan, Xuming Liu, Wenqing Huang, Jian Geng, and Jun Zhou. Csrp2 suppresses colorectal cancer progression via p130cas/rac1 axis-meditated erk, pak, and hippo signaling pathways. Theranostics, 10(24):11063–11079, 2020. URL: http://dx.doi.org/10.7150/thno.45674, doi:10.7150/thno.45674. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.45674)

[3. (Kloiber1999Mutational) Karin Kloiber, Ralf Weiskirchen, Bernhard Kräutler, Klaus Bister, and Robert Konrat. Mutational analysis and nmr spectroscopy of quail cysteine and glycine-rich protein crp2 reveal an intrinsic segmental flexibility of lim domains. Journal of Molecular Biology, 292(4):893–908, October 1999. URL: http://dx.doi.org/10.1006/jmbi.1999.3118, doi:10.1006/jmbi.1999.3118. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1006/jmbi.1999.3118)

[4. (WEISKIRCHEN2001LIMdomain) Ralf WEISKIRCHEN, Markus MOSER, Sabine WEISKIRCHEN, Martin ERDEL, Sandra DAHMEN, Reinhard BUETTNER, and Axel M. GRESSNER. Lim-domain protein cysteine- and glycine-rich protein 2 (crp2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated stat1. Biochemical Journal, 359(3):485, November 2001. URL: http://dx.doi.org/10.1042/0264-6021:3590485, doi:10.1042/0264-6021:3590485. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/0264-6021:3590485)

[5. (Lin2008Transforming) Da-Wei Lin, Il-Chi Chang, Alan Tseng, Meng-Ling Wu, Chung-Huang Chen, Cassandra A. Patenaude, Matthew D. Layne, and Shaw-Fang Yet. Transforming growth factor β up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. Journal of Biological Chemistry, 283(22):15003–15014, May 2008. URL: http://dx.doi.org/10.1074/jbc.M801621200, doi:10.1074/jbc.m801621200. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M801621200)

[6. (Weiskirchen2003The) Ralf Weiskirchen and Kalle Günther. The crp/mlp/tlp family of lim domain proteins: acting by connecting. BioEssays, 25(2):152–162, January 2003. URL: http://dx.doi.org/10.1002/bies.10226, doi:10.1002/bies.10226. This article has 88 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/bies.10226)

[7. (Grubinger2003CRP2) Markus Grubinger and Mario Gimona. Crp2 is an autonomous actin‐binding protein. FEBS Letters, 557(1–3):88–92, December 2003. URL: http://dx.doi.org/10.1016/s0014-5793(03)01451-0, doi:10.1016/s0014-5793(03)01451-0. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-5793(03)01451-0)

[8. (Wu2014Divergent) Meng-Ling Wu, Chung-Huang Chen, Yung-Tsang Lin, Yuan-Jyun Jheng, Yen-Chun Ho, Liang-Tung Yang, Linyi Chen, Matthew D Layne, and Shaw-Fang Yet. Divergent signaling pathways cooperatively regulate tgfβ induction of cysteine-rich protein 2 in vascular smooth muscle cells. Cell Communication and Signaling, March 2014. URL: http://dx.doi.org/10.1186/1478-811X-12-22, doi:10.1186/1478-811x-12-22. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1478-811X-12-22)

[9. (Sagave2008Targeted) Julia F Sagave, Markus Moser, Elisabeth Ehler, Sabine Weiskirchen, Doris Stoll, Kalle Günther, Reinhard Büttner, and Ralf Weiskirchen. Targeted disruption of the mouse csrp2gene encoding the cysteine- and glycine-rich lim domain protein crp2 result in subtle alteration of cardiac ultrastructure. BMC Developmental Biology, August 2008. URL: http://dx.doi.org/10.1186/1471-213X-8-80, doi:10.1186/1471-213x-8-80. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-213X-8-80)